High Flow Nasal Cannula Rates in Pediatric Asthma

Status Not yet recruiting

Clinical Trial Summary

This is a randomized, open-label, 3-armed feasibility trial will examine conventional oxygen therapy (COT) vs high flow nasal cannula at 4L/min flow vs HFNC at 2L/kg/min flow (max 60L/min) in moderate to severe pediatric asthma exacerbations.

Clinical Trial Description

The purpose of this feasibility trial is to examine the safety and efficacy of high flow nasal cannula in moderate to severe pediatric asthma exacerbations. Eligible patients will be admitted to the Pediatric Intensive Care Unit (PICU) after initial presentation to the emergency department (ED) or as a transfer from an outside hospital ED. Patients will be admitted to the PICU on standard asthma therapy (continuous albuterol and systemic corticosteroids) based on the discretion of the treating ED physician. Upon PICU admission, eligible patients will be consented, enrolled, and randomized into the study. All patients will be continued on standard asthma therapy of continuous albuterol at 20mg/hr and systemic intravenous corticosteroids. Patient will be randomized into one of three groups: (1) conventional oxygen therapy at 2L/min via standard facemark (control group), (2) high flow nasal cannula at 4L/min, and (3) high flow nasal cannula at 2L/kg/min (max 60L/min). Pediatric Asthma Severity Scores (PASS) and vital signs will be taken at baseline and hourly for two hours. After the two-hour long study is completed, patients will be placed on a respiratory support modality as per the treating physician's discretion. Patients will be followed longitudinally after study completion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06379607
Study type	Interventional
Source	University of Rochester
Contact	Michele E Smith, MD
Phone	5182296501
Email	michele_smith@urmc.rochester.edu
Status	Not yet recruiting
Phase	N/A
Start date	October 1, 2024
Completion date	September 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05706571` - Child Patient End-of-Life Care Module	N/A
Not yet recruiting	`NCT05999032` - The Puerto Rico Asthma Integrated Response Program ("PR-AIR")	N/A
Completed	`NCT03933540` - Association Between Activity and PROMIS Pediatric Measures in Children With Asthma
Active, not recruiting	`NCT03842033` - Implementing a Guidelines-Based M-Health Intervention for High Risk Asthma Patients	N/A
Not yet recruiting	`NCT06321471` - AeviceMD for Pediatric Asthma Management	N/A
Not yet recruiting	`NCT05826561` - Developing a Childhood Asthma Risk Passive Digital Marker	N/A
Recruiting	`NCT05608668` - Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma	N/A
Completed	`NCT04865575` - Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
Completed	`NCT03814018` - Bronchoreversibility Test in Asthmatic Children and Correlation With Diagnostic Criteria Proposed by the GINA Guidelines
Recruiting	`NCT06112080` - Wearable Auscultation Device Validation in Children
Completed	`NCT01650844` - School-Based Telemedicine Enhanced Asthma Management	N/A
Completed	`NCT01326182` - Intervention for Depressed Latina Mothers of Children With Asthma	Phase 2
Recruiting	`NCT06223828` - Azithromycin for Critical Asthma - Pediatrics	Phase 2/Phase 3
Not yet recruiting	`NCT06278662` - Cohort Multiple Randomized Controlled Trial in Pediatric Asthma	N/A
Not yet recruiting	`NCT05945355` - Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)	N/A